WINCHESTER, Mass.--(BUSINESS WIRE)--CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming and self-anchoring technology for Transcatheter Mitral Valve Implantation (TMVI), today announced that it has elected Nancy Briefs as a director, effective immediately.
